Category - New Drugs
FDA Approves Ebglyss (lebrikizumab-lbkz) for the Treatment of Atopic Dermatitis
FDA Approves Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) Subcutaneous Anti-PD-(L)1 Cancer Immunotherapy
Travere Therapeutics Announces Full FDA Approval of Filspari (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy
FDA Approves Boruzu (bortezomib) Ready-to-Use Injection for Multiple Myeloma and Mantle Cell Lymphoma
Azurity Pharmaceuticals, Inc. Announces FDA Approval of Nymalize (nimodipine) Oral Solution 30 mg/5 mL Prefilled ENFit® Syringe
Emergent BioSolutions’ ACAM2000 (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication
FDA Approves Pavblu (aflibercept-ayyh), a Biosimilar to Eylea
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine Targeting KP.2 Variant of SARS-CoV-2